(Q35653388)

9 August 2017

title

Variables influencing susceptibility testing of Cryptococcus neoformans to 5-fluorocytosine (English)

1 reference

9 August 2017

1 reference

Cryptococcus neoformans

1 reference

Block ER

1 reference

9 August 2017

Jennings AE

series ordinal

1 reference

9 August 2017

Bennett JE

series ordinal

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 October 1973

1 reference

Antimicrobial Agents and Chemotherapy

9 August 2017

published in

1 reference

9 August 2017

1 reference

9 August 2017

1 reference

9 August 2017

page(s)

392-395

1 reference

Further in vitro studies with 5-fluorocytosine.

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444565

In Vitro Studies with 5-Fluorocytosine

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444565

In vitro activity of 5-fluorocytosine against Candida and Torulopsis species

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444565

5-fluorocytosine resistance in Cryptococcus neoformans

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444565

In Vitro Studies of 5-Fluorocytosine Resistance in Candida albicans and Torulopsis glabrata

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444565

5-Fluorocytosine in the Treatment of Mycotic Infections

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444565

In vitro susceptibility of Cryptococcus neoformans to amphotericin B, hamycin, and 5-fluorocytosine

25 September 2018

1 reference

12 December 2020

5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience

1 reference

12 December 2020

Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine

1 reference

12 December 2020

Candida at Boston City Hospital. Clinical and epidemiological characteristics and susceptibility to eight antimicrobial agents

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.4.4.392

1 reference

9 August 2017

1 reference

9 August 2017

1 reference